These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 15331065
1. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Choudhury J, Sanyal AJ. Clin Liver Dis; 2004 Aug; 8(3):575-94, ix. PubMed ID: 15331065 [Abstract] [Full Text] [Related]
2. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Verna EC, Berk PD. Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297 [Abstract] [Full Text] [Related]
4. Pathogenesis of nonalcoholic steatohepatitis (NASH). Ma X, Li Z. Chin J Dig Dis; 2006 Feb; 7(1):7-11. PubMed ID: 16412031 [Abstract] [Full Text] [Related]
5. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Parekh S, Anania FA. Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512 [Abstract] [Full Text] [Related]
6. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Willner IR, Waters B, Patil SR, Reuben A, Morelli J, Riely CA. Am J Gastroenterol; 2001 Oct; 96(10):2957-61. PubMed ID: 11693332 [Abstract] [Full Text] [Related]
7. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S. Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878 [Abstract] [Full Text] [Related]
9. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. Boza C, Riquelme A, Ibañez L, Duarte I, Norero E, Viviani P, Soza A, Fernandez JI, Raddatz A, Guzman S, Arrese M. Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788 [Abstract] [Full Text] [Related]
10. Nonalcoholic fatty liver disease as a complication of insulin resistance. Abdelmalek MF, Diehl AM. Med Clin North Am; 2007 Nov; 91(6):1125-49, ix. PubMed ID: 17964913 [Abstract] [Full Text] [Related]
11. [Nonalcoholic steatohepatitis: pathogenesis and treatment]. Park SH. Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854 [Abstract] [Full Text] [Related]
12. The potential role of genes in nonalcoholic fatty liver disease. Day CP. Clin Liver Dis; 2004 Aug; 8(3):673-91, xi. PubMed ID: 15331069 [Abstract] [Full Text] [Related]
14. The emerging problem of nonalcoholic steatohepatitis (NASH). Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. Rom J Gastroenterol; 2005 Mar; 14(1):43-51. PubMed ID: 15800693 [Abstract] [Full Text] [Related]
15. Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Méndez-Sánchez N, Arrese M, Zamora-Valdés D, Uribe M. Liver Int; 2007 May; 27(4):423-33. PubMed ID: 17403181 [Abstract] [Full Text] [Related]